Article Information
History
- October 27, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Seth Blumberga,
- Anna Borlaseb,
- Joaquin M Pradac,
- Anthony W Solomond,
- Paul Emersone,
- Pamela J Hoopere,
- Michael S Deinera,
- Benjamin Amoahf,
- Deirdre Hollingsworthb,
- Travis C Porcoa,g and
- Thomas M Lietmana,g,h,i,*
- aFrancis I Proctor Foundation, UCSF, USA
- bUniversity of Oxford, Oxford, UK
- cFaculty of Health and Medical Sciences, University of Surrey, UK
- dDepartment of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
- eInternational Trachoma Initiative, The Task Force for Global Health, USA
- fLancaster Medical School, Lancaster University, Bailrigg, Lancaster, UK
- gDepartment of Epidemiology and Biostatistics, UCSF, USA
- hInstitute for Global Health Sciences, UCSF, USA
- iDepartment of Ophthalmology, UCSF, USA
- ↵*Corresponding author: Thomas M Lietman, 513 Parnassus Ave., San Francisco, CA 94143, Email: Tom.Lietman{at}ucsf.edu, Phone: 415-502-2662
Posted October 27, 2020.
Implications of the COVID-19 pandemic on eliminating trachoma as a public health problem
